The Clorox Company (NYSE:CLX) Shares Purchased by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC boosted its holdings in The Clorox Company (NYSE:CLXFree Report) by 19.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 329,271 shares of the company’s stock after purchasing an additional 53,186 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Clorox were worth $46,951,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Norges Bank purchased a new position in shares of Clorox in the 4th quarter valued at $101,609,000. Imprint Wealth LLC lifted its stake in shares of Clorox by 16,986.8% during the second quarter. Imprint Wealth LLC now owns 551,392 shares of the company’s stock worth $55,139,000 after purchasing an additional 548,165 shares in the last quarter. Qube Research & Technologies Ltd lifted its stake in shares of Clorox by 75.9% during the third quarter. Qube Research & Technologies Ltd now owns 1,130,481 shares of the company’s stock worth $148,161,000 after purchasing an additional 487,974 shares in the last quarter. International Assets Investment Management LLC boosted its position in shares of Clorox by 17,658.5% in the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after buying an additional 481,725 shares during the period. Finally, Acadian Asset Management LLC grew its stake in shares of Clorox by 39.6% in the third quarter. Acadian Asset Management LLC now owns 1,467,713 shares of the company’s stock valued at $192,319,000 after buying an additional 415,999 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Jefferies Financial Group raised Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target on the stock in a research report on Tuesday, March 26th. DA Davidson restated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a research note on Monday, February 5th. Citigroup reaffirmed a “neutral” rating and set a $165.00 price target (down from $170.00) on shares of Clorox in a report on Tuesday, April 2nd. Barclays cut their price objective on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a report on Wednesday. Finally, Bank of America upgraded Clorox from an “underperform” rating to a “neutral” rating and raised their target price for the company from $120.00 to $150.00 in a research note on Friday, December 15th. Four research analysts have rated the stock with a sell rating and twelve have assigned a hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $149.13.

View Our Latest Report on CLX

Clorox Stock Performance

CLX stock opened at $144.80 on Friday. The firm has a market cap of $17.97 billion, a P/E ratio of 229.84, a P/E/G ratio of 2.26 and a beta of 0.43. The stock’s 50 day simple moving average is $151.48 and its 200 day simple moving average is $141.29. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The Clorox Company has a 12-month low of $114.68 and a 12-month high of $178.21.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.08 by $1.08. Clorox had a net margin of 1.09% and a return on equity of 319.41%. The company had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same period in the prior year, the company earned $0.98 earnings per share. The firm’s revenue was up 16.0% compared to the same quarter last year. As a group, equities research analysts predict that The Clorox Company will post 5.51 EPS for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be issued a $1.20 dividend. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.31%. Clorox’s dividend payout ratio is currently 761.92%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.